NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

Warehouse drops guidance, loss now in scope
Retail

Warehouse drops guidance, loss now in scope

The retailer has raised the possibility of a full-year earnings loss.

Xero’s Melio ‘leap of faith’
Markets Analysis

Xero’s Melio ‘leap of faith’

The NZ-founded company’s giant-killer dreams in the US hinge on this huge bet. 

NZX ends half year down 3.6%
Markets Market Close

NZX ends half year down 3.6%

"We’ve continued to lag relative to other markets," analyst says.

Gregor Thompson 30 Jun 2025